Literature DB >> 1576182

Lifetime and six-month prevalence of mental disorders in the Munich Follow-Up Study.

H U Wittchen1, C A Essau, D von Zerssen, J C Krieg, M Zaudig.   

Abstract

The Lifetime and 6 month DSM-III prevalence rates of mental disorders from an adult general population sample of former West Germany are reported. The most frequent mental disorders (lifetime) from the Munich Follow-up Study were anxiety disorders (13.87%), followed by substance (13.51%) and affective (12.90%) disorders. Within anxiety disorders, simple and social phobia (8.01%) were the most common, followed by agoraphobia (5.47%) and panic disorder (2.39%). Females had about twice the rates of males for affective (18.68% versus 6.42%), anxiety (18.13% versus 9.07%), and somatization disorders (1.60% versus 0.00%); males had about three times the rates of substance disorders (21.23% versus 6.11%) of females. Being widowed and separated/divorced was associated with high rates of major depression. Most disordered subjects had at least two diagnoses (69%). The most frequent comorbidity pattern was anxiety and affective disorders. Simple and social phobia began mostly in childhood or early adolescence, whereas agoraphobia and panic disorder had a later average age of onset. The majority of the cases with both anxiety and depression had depression clearly after the occurrence of anxiety. The DIS-DSM-III findings of our study have been compared with both ICD-9 diagnoses assigned by clinicians independently as well as other epidemiological studies conducted with a comparable methodology.

Entities:  

Mesh:

Year:  1992        PMID: 1576182     DOI: 10.1007/bf02190261

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  32 in total

1.  [The course of treated and untreated depressions and anxiety disorders. A clinico-psychiatric and epidemiological follow-up study].

Authors:  H U Wittchen; D von Zerssen
Journal:  Monogr Gesamtgeb Psychiatr Psychiatry Ser       Date:  1988

2.  The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance.

Authors:  J Endicott; R L Spitzer; J L Fleiss; J Cohen
Journal:  Arch Gen Psychiatry       Date:  1976-06

3.  Prevalence of psychiatric disorders in Taiwan defined by the Chinese Diagnostic Interview Schedule.

Authors:  H G Hwu; E K Yeh; L Y Chang
Journal:  Acta Psychiatr Scand       Date:  1989-02       Impact factor: 6.392

4.  National Institute of Mental Health Diagnostic Interview Schedule. Its history, characteristics, and validity.

Authors:  L N Robins; J E Helzer; J Croughan; K S Ratcliff
Journal:  Arch Gen Psychiatry       Date:  1981-04

5.  The Social Interview Schedule (SIS)--content, structure and reliability.

Authors:  T Faltermaier; H U Wittchen; R Ellmann; R Lässle
Journal:  Soc Psychiatry       Date:  1985

6.  Lifetime and 6-month prevalence of abuse and dependence of alcohol in the Munich Follow-up Study.

Authors:  T Bronisch; H U Wittchen
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1992       Impact factor: 5.270

7.  The co-occurrence of alcoholism with other psychiatric disorders in the general population and its impact on treatment.

Authors:  J E Helzer; T R Pryzbeck
Journal:  J Stud Alcohol       Date:  1988-05

8.  Lifetime prevalence of psychiatric disorders in Edmonton.

Authors:  R C Bland; H Orn; S C Newman
Journal:  Acta Psychiatr Scand Suppl       Date:  1988

9.  The Zurich Study. V. Anxiety and phobia in young adults.

Authors:  J Angst; A Dobler-Mikola
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1985

10.  Epidemiologic evidence for early onset of mental disorders and higher risk of drug abuse in young adults.

Authors:  K A Christie; J D Burke; D A Regier; D S Rae; J H Boyd; B Z Locke
Journal:  Am J Psychiatry       Date:  1988-08       Impact factor: 18.112

View more
  62 in total

1.  The epidemiology of major depressive episodes: results from the International Consortium of Psychiatric Epidemiology (ICPE) Surveys.

Authors:  Laura Andrade; Jorge J Caraveo-Anduaga; Patricia Berglund; Rob V Bijl; Ron De Graaf; Wilma Vollebergh; Eva Dragomirecka; Robert Kohn; Martin Keller; Ronald C Kessler; Norito Kawakami; Cengiz Kiliç; David Offord; T Bedirhan Ustun; Hans-Ulrich Wittchen
Journal:  Int J Methods Psychiatr Res       Date:  2003       Impact factor: 4.035

Review 2.  Depression as a risk factor for underuse of mammography.

Authors:  Hillary R Bogner; Marsha N Wittink
Journal:  J Womens Health (Larchmt)       Date:  2004 Jul-Aug       Impact factor: 2.681

3.  The relationship between cannabis use disorders and social anxiety disorder in the National Epidemiological Study of Alcohol and Related Conditions (NESARC).

Authors:  Julia D Buckner; Richard G Heimberg; Franklin R Schneier; Shang-Min Liu; Shuai Wang; Carlos Blanco
Journal:  Drug Alcohol Depend       Date:  2012-01-21       Impact factor: 4.492

4.  Primary care mental health and Alma-Ata: from evidence to action.

Authors:  Gabriel Ivbijaro; Lucja Kolkiewicz; Christos Lionis; Igor Svab; Alan Cohen; Norman Sartorius
Journal:  Ment Health Fam Med       Date:  2008-06

5.  Prevalence of mental and social disorders in adults attending primary care centers in Bosnia and Herzegovina.

Authors:  Teresa Broers; Geoffrey Hodgetts; Olivera Batić-Mujanović; Verica Petrović; Melida Hasanagić; Marshall Godwin
Journal:  Croat Med J       Date:  2006-06       Impact factor: 1.351

6.  The prevalence and correlates of nonaffective psychosis in the National Comorbidity Survey Replication (NCS-R).

Authors:  Ronald C Kessler; Howard Birnbaum; Olga Demler; Ian R H Falloon; Elizabeth Gagnon; Margaret Guyer; Mary J Howes; Kenneth S Kendler; Lizheng Shi; Ellen Walters; Eric Q Wu
Journal:  Biol Psychiatry       Date:  2005-07-14       Impact factor: 13.382

7.  Somatization in the population: from mild bodily misperceptions to disabling symptoms.

Authors:  Wolfgang Hiller; Winfried Rief; Elmar Brähler
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2006-06-22       Impact factor: 4.328

8.  Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Wai Tat Chiu; Olga Demler; Kathleen R Merikangas; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2005-06

9.  Possible association of the GSK3β gene with the anxiety symptoms of major depressive disorder and P300 waveform.

Authors:  Sha Liu; Ning Sun; Yong Xu; Chunxia Yang; Yan Ren; Zhifen Liu; Xiaohua Cao; Yan Sun; Qi Xu; Kerang Zhang; Yan Shen
Journal:  Genet Test Mol Biomarkers       Date:  2012-10-02

10.  Frequency of hospitalisations and inpatient care costs of manic episodes: in patients with bipolar I disorder in France.

Authors:  Marie de Zelicourt; Roland Dardennes; Hélène Verdoux; Gian Gandhi; Babak Khoshnood; Eric Chomette; Marie-Laure Papatheodorou; Eric T Edgell; Christian Even; Francis Fagnani
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.